• About online consultations

  • 30 Consultation

  • 60 Consultation

  • 30 min Review & 30 min Consultation
    ※Online consultation will be in the latter 30 minutes.
    ※Please send the manuscript by 2-5 days prior to the date of the session(consult@enago.com)

Timothy Chaston

Country: Australia

Qualification: Ph.D. under the Iron Metabolism and Chelation Program; University of New South Wales

Communication style

Experienced mentor, will speak slow in easy English, and has interacted with ESL researchers.

  1. Instructor profile
Timothy is an experienced biomedical researcher. He has conducted research at reputed organizations and has affiliations with various societies. Timothy is available for consultation sessions on topics related to academic writing and publishing. He also has the relevant technical writing experience.
  • Fifteen high-quality journal publications and a monograph.
  • Seven years of biomedical laboratory and teaching experience.
  • Ten years of scientific and medical writing experience.
  • Eight years of presenting experience at international conferences.
  • Medical, pharmaceutical, and academic work history.
Employment History
  • 2006–2009: Postdoctoral Research Associate; King’s College London, London UK.
  • 2005–2006: Medical writer; Centre for Obesity Research and Education, Monash University, Melbourne Australia.
  • 2004–2005: Technical writer; Mayne Pharmaceuticals, Melbourne Australia. Preparation and cyclical review of SOP’s and OI’s conforming to prescribed style and format.
  • 2004, 2006: Contract Scientific Writer; Holding Redlich Law firm: Systematic literature review of stress-related CVD outcomes. ESH connect inc: Literature review of industrial pollutants and health risks.
  • 2001–2004: PhD Student; University of New South Wales, Sydney Australia.
  • 2000–2001: Store Manager; Heart Research Institute, Sydney Australia.
  • Bachelor of Applied Science (BAppSci): Environmental and Analytical Chemistry, University of Canberra. 1999
  • Doctor of Philosophy (PhD): Iron Metabolism and Chelation Program, Children's Cancer Institute Australia for Medical Research. Department of Paediatrics, University of New South Wales. 2004
  • TB Chaston, P Matak , K Pourvali, SK Srai, AT McKie, PA Sharp. (2011) Am J Physiol Cell Physiol. Hypoxia inhibits hepcidin expression in HuH7 hepatoma cells via decreased SMAD4 signaling.
  • SK Srai, B Chung, J Marks, K Pourvali, N Solanky, C Rapisarda, TB Chaston, R Hanif, RJ Unwin, ES Debnam, PA Sharp. (2010) Kidney Int. Oct;78(7):660-7. Erythropoietin regulates intestinal iron absorption in a rat model of chronic renal failure.
  • TB Chaston and DR Richardson 2009. Verlag Dr. Muller publishing. ISBN: 978-3-639-14780-3. Cytotoxic Mechanisms of Iron Chelators with Therapeutic Potential.
  • B Chung, T Chaston, J Marks, SK Srai, PA Sharp. (2009) J Nutr.Aug;139(8):1457-62. Hepcidin decreases iron transporter expression in vivo in mouse duodenum and spleen and in vitro in THP-1 macrophages and intestinal Caco-2 cells.
  • P Matak, TB Chaston, B Chung, SK Srai, AT McKie, PA Sharp. (2009) Haematologica. Jun;94(6):773-80. Activated macrophages induce hepcidin expression in HuH7 hepatoma cells.
  • TB Chaston, JB Dixon. (2008) Int J Obes (Lond). 32(4):619-28. Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review.
  • T Chaston, B Chung, M Mascarenhas, J Marks, B Patel, SK Srai, P Sharp. (2008) Gut. 57(3):374-82. Evidence for differential effects of hepcidin in macrophages and intestinal epithelial cells.
  • VP Alvarez, JB Dixon, BJ Strauss, CP Laurie, TB Chaston, PE O'Brien. (2007) Obes Surg. Feb;17(2):211-21. Single frequency bioelectrical impedance is a poor method for determining fat mass in moderately obese women.
  • PE O’Brien, T McPhail, TB Chaston and JB Dixon. (2006) Obesity Surgery. Systematic review of medium-term weight loss after bariatric procedures.
  • TB Chaston, JB Dixon and PE O’Brien. (2006) International Journal of Obesity. Changes in fat-free mass during significant weight loss: a systematic review.
  • TB Chaston, RN Watts, J Yuan, and DR Richardson. (2004) Clinical Cancer Research 10(21):7365-74. The Potent Anti-Tumor Activity of Novel Iron Chelators Derived from Di-2-Pyridylketone Isoicotinoyl Hydrazone Involves Fenton-Derived Free Radical Generation.
  • PV Bernhardt, LM Caldwell, TB Chaston, P Chin and DR Richardson. (2003) Journal of Biological and Inorganic Chemistry 8:866-880. Cytotoxic iron chelators: characterization of the structure, solution chemistry and redox activity of ligands and iron complexes of the di-2-pyridyl ketone isonicotinoyl hydrazone (HPKIH) analogues.
  • TB Chaston and DR Richardson. (2003) American Journal of Hematology 73:200-210. Iron Chelators for the Treatment of Iron Overload Disease: Relationship Between Structure, Redox Activity, and Toxicity.
  • TB Chaston and DR Richardson. (2003) Journal of Biological and Inorganic Chemistry 8:427-438. Interactions of the pyridine-2-carboxaldehyde isonicotinoyl hydrazone class of chelators with iron and DNA: implications for toxicity in the treatment of iron overload disease.
  • TB Chaston, DB Lovejoy, RN Watts, DR Richardson. (2003) Clinical Cancer Research 9:402-414. Examination of the Antiproliferative Activity of Iron Chelators: Multiple Cellular Targets and the Different Mechanisms of Action of Triapine Compared with Desferrioxamine and the Potent Pyridoxal Isonicotinoyl Hydrazone Analogue 311.
  • TB Chaston and BA Lidbury. (2001) Immunology and Cell Biology 79:62-64. Genetic ‘budget’ of viruses and the cost to the infected host: A theory on the relationship between the genetic capacity of viruses, immune evasion, persistence and disease.

Read More >> Read Less >>

Book an Appointment


$49 | 30 minutes


$89 | 60 minutes

30 min Review & 30 min Consultation

$89 | 60 minutes